Showing results (901-910 of 962) with videos related to

Sort By:
Pageof 97
The EMBO Journal|December 19, 1998
A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factorY Izumi, M Hirata, H Hasuwa, et al.
Archives of Oral Biology|June 28, 2003
Mechanical stimuli enhances the expression of RGD-CAP/betaig-h3 in the periodontal ligamentT Doi, S Ohno, K Tanimoto, et al.
The European Respiratory Journal|February 7, 2009
Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injuryN Mato, M Fujii, Y Hakamata, et al.
Investigative Ophthalmology & Visual Science|October 29, 2000
Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populationsN Mizuki, M Ota, K Yabuki, et al.
Cancer Communications|June 1, 1991
Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoproteinG Yu, S Ahmad, A Aquino, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 13, 2001
[Pulmonary hypertension in a patient with primary Sjogren's syndrome, Hashimoto's disease, and primary biliary cirrhosis]A Aoki, H Kenmochi, E Hagiwara, et al.
Tissue Antigens|September 1, 1996
Genetic polymorphisms in the keratin-like S gene within the human major histocompatibility complex and association analysis on the susceptibility to psoriasis vulgarisM Ishihara, N Yamagata, S Ohno, et al.
Free Radical Biology & Medicine|July 9, 1998
Spatiotemporal measurement of free radical elimination in the abdomen using an in vivo ESR-CT imaging systemH Togashi, H Shinzawa, T Ogata, et al.
International Archives of Allergy and Immunology|November 1, 1994
Differential expression of protein kinase C genes in cultured mast cells derived from normal and mast-cell-deficient mice and mast cell linesH M Kim, S Hirota, H T Chung, et al.
Cancer Chemotherapy and Pharmacology|May 30, 2014
A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancerN Masuda, K Higaki, T Takano, et al.
Pageof 97